Guolin Ye

Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study

Xiaosong Chen, Guolin Ye, Chenfang Zhang et al. · Chinese Journal of Cancer Research · 2016 · 69 citations · Full text

Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer

Xiaosong Chen, Guolin Ye, Chenfang Zhang et al. · Breast Cancer Research and Treatment · 2013 · 44 citations

Natt Trial, Breast Oncology, Oncology +9

<p>BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer</p>

Lewei Zhu, Ruilin Pan, Dan Zhou et al. · Cancer Management and Research · 2019 · 40 citations · Full text

Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer：A multicenter study

Bao Li, Fengling Li, Zhenyu Liu et al. · The Breast · 2022 · 40 citations · Full text

Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway

Guolin Ye, Ruilin Pan, Leiwei Zhu et al. · Experimental and Molecular Pathology · 2020 · 30 citations

Lineage Plasticity, Developmental Biology, Medicine +11